• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATH

ALTERITY THERAPEUTICS LIMITED - Announcements

15.4% ! 1.5¢
Market Cap $138.1M  !

Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company.... Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements



ATH Appendix 4C and Quarterly Cash Flow ReportPRICE SENSITIVE29/10/21 download Created with Sketch. 1.81MB
ATH Expanded ATH434 Phase 2 Clinical Development ProgramPRICE SENSITIVE19/10/21 download Created with Sketch. 281.81KB
ATH Notice of Annual General Meeting/Proxy Form11/10/21 download Created with Sketch. 744.93KB
ATH Presentation of New Biomarker Data at Scientific Congress20/09/21 download Created with Sketch. 259.71KB
ATH Form 20-FPRICE SENSITIVE03/09/21 download Created with Sketch. 776.23KB
ATH ATH filed Form 20-F and XBRL data with SEC03/09/21 download Created with Sketch. 202.4KB
ATH Change in substantial holding01/09/21 download Created with Sketch. 1.88MB
ATH Appendix 4G and Corporate Governance Statement 202101/09/21 download Created with Sketch. 344.87KB
ATH Appendix 4E & Annual Report 2021PRICE SENSITIVE01/09/21 download Created with Sketch. 2.76MB
ATH Change in substantial holding12/08/21 download Created with Sketch. 1.07MB
ATH New US Patent Expands Neurodegeneration Treatment PortfolioPRICE SENSITIVE04/08/21 download Created with Sketch. 250.2KB
ATH Appendix 4C and Quarterly Cash Flow ReportPRICE SENSITIVE30/07/21 download Created with Sketch. 411.12KB
ATH New Publication Demonstrates ATH434 is NeuroprotectivePRICE SENSITIVE15/07/21 download Created with Sketch. 348.84KB
ATH Change in substantial holding13/07/21 download Created with Sketch. 1.05MB
ATH Change in substantial holding09/07/21 download Created with Sketch. 929.29KB
ATH Change in substantial holding09/07/21 download Created with Sketch. 1.06MB
ATH Change in substantial holding08/07/21 download Created with Sketch. 1.82MB
ATH Change in substantial holding06/07/21 download Created with Sketch. 1.82MB
ATH Notice under section 708A(5) of the Corporations Act05/07/21 download Created with Sketch. 122.07KB
ATH Application for quotation of securities - ATH05/07/21 download Created with Sketch. 24.72KB
ATH Proposed issue of securities - ATH02/07/21 download Created with Sketch. 24.81KB
ATH New US patent targeting major neurodegenerative diseasesPRICE SENSITIVE01/07/21 download Created with Sketch. 233.13KB
ATH Change in substantial holding30/06/21 download Created with Sketch. 1.15MB
ATH EU Regulatory Guidance for ATH434 Phase 2 Clinical TrialPRICE SENSITIVE23/06/21 download Created with Sketch. 212.4KB
ATH Investor PresentationPRICE SENSITIVE17/06/21 download Created with Sketch. 2.01MB
ATH Alterity to present at MST Access Investor Conference16/06/21 download Created with Sketch. 203.32KB
ATH Appendix 4C and Quarterly Cash Flow ReportPRICE SENSITIVE29/04/21 download Created with Sketch. 418.29KB
ATH Change in substantial holding28/04/21 download Created with Sketch. 1.88MB
ATH Ceasing to be a substantial holder23/04/21 download Created with Sketch. 81.12KB
ATH ATH434 protects brain cells and improves motor functionPRICE SENSITIVE21/04/21 download Created with Sketch. 220.99KB
ATH Appendix 3G20/04/21 download Created with Sketch. 344.53KB
ATH Change in substantial holding15/03/21 download Created with Sketch. 84.53KB
ATH Alterity to present at Global Life Science ConferencePRICE SENSITIVE10/03/21 download Created with Sketch. 1.79MB
ATH Change in substantial holding26/02/21 download Created with Sketch. 84.29KB
ATH Alterity to present at 7th International Congress of MSA26/02/21 download Created with Sketch. 199.71KB
ATH Half Yearly Report and AccountsPRICE SENSITIVE25/02/21 download Created with Sketch. 373.54KB
ATH Change in substantial holding22/02/21 download Created with Sketch. 1.88MB
ATH Alterity Half Year Results and Investor Webcast Notification19/02/21 download Created with Sketch. 193.9KB
ATH Change in substantial holding16/02/21 download Created with Sketch. 1.05MB
ATH Change in substantial holding15/02/21 download Created with Sketch. 83.16KB
ATH Change in substantial holding15/02/21 download Created with Sketch. 1.88MB
ATH Change in substantial holding12/02/21 download Created with Sketch. 82.47KB
ATH Appendix 2A and Section 708A(5) Cleansing Notice11/02/21 download Created with Sketch. 376.65KB
ATH Change in substantial holding11/02/21 download Created with Sketch. 1.06MB
ATH Proposed issue of Securities - ATH10/02/21 download Created with Sketch. 24.45KB
ATH Michael J Fox grant for Parkinson's research on ATH434PRICE SENSITIVE09/02/21 download Created with Sketch. 192.69KB
ATH Appendix 4C and Quarterly Cash Flow ReportPRICE SENSITIVE28/01/21 download Created with Sketch. 338.79KB
ATH Change in substantial holding14/01/21 download Created with Sketch. 83.8KB
ATH Alterity participates in JP Morgan healthcare conferencePRICE SENSITIVE11/01/21 download Created with Sketch. 201KB
ATH Dr David Stamler Appointed CEOPRICE SENSITIVE07/01/21 download Created with Sketch. 258.79KB
ATH Change in substantial holding29/12/20 download Created with Sketch. 1.06MB
ATH Form F-3PRICE SENSITIVE24/12/20 download Created with Sketch. 300.42KB
ATH New commercial opportunity for PBT2PRICE SENSITIVE21/12/20 download Created with Sketch. 288.04KB
ATH Change in substantial holding18/12/20 download Created with Sketch. 1.88MB
ATH Form 6-K17/12/20 download Created with Sketch. 236.7KB
ATH Prospectus Supplement17/12/20 download Created with Sketch. 663.67KB
ATH Change in substantial holding10/12/20 download Created with Sketch. 1.06MB
ATH Change in substantial holding04/12/20 download Created with Sketch. 1.06MB
ATH Form S-803/12/20 download Created with Sketch. 175.12KB
ATH Alterity presents at Finance News NetworkPRICE SENSITIVE02/12/20 download Created with Sketch. 756.28KB
ATH Change in substantial holding01/12/20 download Created with Sketch. 961.12KB
ATH Change in substantial holding01/12/20 download Created with Sketch. 1.89MB
ATH Becoming a substantial holder26/11/20 download Created with Sketch. 83.47KB
ATH Change in substantial holding26/11/20 download Created with Sketch. 205.8KB
ATH Change in substantial holding25/11/20 download Created with Sketch. 1.88MB
ATH Prospectus filed pursuant to SEC Rule 424(b)(3)PRICE SENSITIVE24/11/20 download Created with Sketch. 261.13KB
ATH Appendix 3G24/11/20 download Created with Sketch. 344.97KB
ATH Appendix 2A and Section 708A(5) Cleansing Notice24/11/20 download Created with Sketch. 377.12KB
ATH Change in substantial holding24/11/20 download Created with Sketch. 266.43KB
ATH Change in substantial holding23/11/20 download Created with Sketch. 1.95MB
ATH Change in substantial holding19/11/20 download Created with Sketch. 1.89MB
ATH ATH Constitution (amended)18/11/20 download Created with Sketch. 433.08KB
ATH Results of Annual General Meeting18/11/20 download Created with Sketch. 190.51KB
ATH ATH Annual General Meeting PresentationPRICE SENSITIVE18/11/20 download Created with Sketch. 1.83MB
ATH Chairman's Address 2020 Annual General MeetingPRICE SENSITIVE18/11/20 download Created with Sketch. 235.47KB
ATH Ceasing to be a substantial holder16/11/20 download Created with Sketch. 479.12KB
ATH Form F-316/11/20 download Created with Sketch. 476.25KB
ATH Ceasing to be a substantial holder16/11/20 download Created with Sketch. 244.1KB
ATH US patent for next generation neurodegenerative diseasesPRICE SENSITIVE16/11/20 download Created with Sketch. 180.99KB
ATH Becoming a substantial holder13/11/20 download Created with Sketch. 525.91KB
ATH Appendix 4C and Quarterly Cash Flow ReportPRICE SENSITIVE30/10/20 download Created with Sketch. 353.74KB
ATH MSA patients enrolled in bioMUSE StudyPRICE SENSITIVE27/10/20 download Created with Sketch. 184.03KB
ATH Change in substantial holding27/10/20 download Created with Sketch. 1.89MB
ATH Change in substantial holding26/10/20 download Created with Sketch. 1.78MB
ATH Alterity completes Placement Tranche 1 raising $10MPRICE SENSITIVE23/10/20 download Created with Sketch. 205.61KB
ATH Appendix 2A and Section 708A(5) Cleansing Notice23/10/20 download Created with Sketch. 368.87KB
ATH Notice of Annual General Meeting/Proxy Form20/10/20 download Created with Sketch. 706.22KB
ATH Proposed issue of Securities - ATH16/10/20 download Created with Sketch. 28.26KB
ATH Proposed issue of Securities - ATH16/10/20 download Created with Sketch. 25.18KB
ATH Alterity raises $35M in placement to institutional investorsPRICE SENSITIVE16/10/20 download Created with Sketch. 234.89KB
ATH Trading HaltPRICE SENSITIVE12/10/20 download Created with Sketch. 164.99KB
ATH Form F-306/10/20 download Created with Sketch. 295KB
ATH Form S-824/09/20 download Created with Sketch. 126.01KB
ATH Change of Director's Interest Notice x 521/09/20 download Created with Sketch. 341.48KB
ATH Appendix 3G Notice of issue of ESOP Options18/09/20 download Created with Sketch. 351.67KB
ATH Form 20-FPRICE SENSITIVE16/09/20 download Created with Sketch. 2.41MB
ATH ATH filed Form 20-F and XBRL data with SEC16/09/20 download Created with Sketch. 175.79KB
ATH Appendix 4G and 2020 Corporate Governance Statement09/09/20 download Created with Sketch. 374.22KB
ATH Annual Report 202009/09/20 download Created with Sketch. 2.37MB
ATH Company update on Annual Report 2020PRICE SENSITIVE09/09/20 download Created with Sketch. 177.51KB
ATH Appendix 4C and Quarterly Cash Flow Report
29/10/21PRICE SENSITIVE download Created with Sketch. 1.81MB
ATH Expanded ATH434 Phase 2 Clinical Development Program
19/10/21PRICE SENSITIVE download Created with Sketch. 281.81KB
ATH Notice of Annual General Meeting/Proxy Form
11/10/21 download Created with Sketch. 744.93KB
ATH Presentation of New Biomarker Data at Scientific Congress
20/09/21 download Created with Sketch. 259.71KB
ATH Form 20-F
03/09/21PRICE SENSITIVE download Created with Sketch. 776.23KB
ATH ATH filed Form 20-F and XBRL data with SEC
03/09/21 download Created with Sketch. 202.4KB
ATH Change in substantial holding
01/09/21 download Created with Sketch. 1.88MB
ATH Appendix 4G and Corporate Governance Statement 2021
01/09/21 download Created with Sketch. 344.87KB
ATH Appendix 4E & Annual Report 2021
01/09/21PRICE SENSITIVE download Created with Sketch. 2.76MB
ATH Change in substantial holding
12/08/21 download Created with Sketch. 1.07MB
ATH New US Patent Expands Neurodegeneration Treatment Portfolio
04/08/21PRICE SENSITIVE download Created with Sketch. 250.2KB
ATH Appendix 4C and Quarterly Cash Flow Report
30/07/21PRICE SENSITIVE download Created with Sketch. 411.12KB
ATH New Publication Demonstrates ATH434 is Neuroprotective
15/07/21PRICE SENSITIVE download Created with Sketch. 348.84KB
ATH Change in substantial holding
13/07/21 download Created with Sketch. 1.05MB
ATH Change in substantial holding
09/07/21 download Created with Sketch. 929.29KB
ATH Change in substantial holding
09/07/21 download Created with Sketch. 1.06MB
ATH Change in substantial holding
08/07/21 download Created with Sketch. 1.82MB
ATH Change in substantial holding
06/07/21 download Created with Sketch. 1.82MB
ATH Notice under section 708A(5) of the Corporations Act
05/07/21 download Created with Sketch. 122.07KB
ATH Application for quotation of securities - ATH
05/07/21 download Created with Sketch. 24.72KB
ATH Proposed issue of securities - ATH
02/07/21 download Created with Sketch. 24.81KB
ATH New US patent targeting major neurodegenerative diseases
01/07/21PRICE SENSITIVE download Created with Sketch. 233.13KB
ATH Change in substantial holding
30/06/21 download Created with Sketch. 1.15MB
ATH EU Regulatory Guidance for ATH434 Phase 2 Clinical Trial
23/06/21PRICE SENSITIVE download Created with Sketch. 212.4KB
ATH Investor Presentation
17/06/21PRICE SENSITIVE download Created with Sketch. 2.01MB
ATH Alterity to present at MST Access Investor Conference
16/06/21 download Created with Sketch. 203.32KB
ATH Appendix 4C and Quarterly Cash Flow Report
29/04/21PRICE SENSITIVE download Created with Sketch. 418.29KB
ATH Change in substantial holding
28/04/21 download Created with Sketch. 1.88MB
ATH Ceasing to be a substantial holder
23/04/21 download Created with Sketch. 81.12KB
ATH ATH434 protects brain cells and improves motor function
21/04/21PRICE SENSITIVE download Created with Sketch. 220.99KB
ATH Appendix 3G
20/04/21 download Created with Sketch. 344.53KB
ATH Change in substantial holding
15/03/21 download Created with Sketch. 84.53KB
ATH Alterity to present at Global Life Science Conference
10/03/21PRICE SENSITIVE download Created with Sketch. 1.79MB
ATH Change in substantial holding
26/02/21 download Created with Sketch. 84.29KB
ATH Alterity to present at 7th International Congress of MSA
26/02/21 download Created with Sketch. 199.71KB
ATH Half Yearly Report and Accounts
25/02/21PRICE SENSITIVE download Created with Sketch. 373.54KB
ATH Change in substantial holding
22/02/21 download Created with Sketch. 1.88MB
ATH Alterity Half Year Results and Investor Webcast Notification
19/02/21 download Created with Sketch. 193.9KB
ATH Change in substantial holding
16/02/21 download Created with Sketch. 1.05MB
ATH Change in substantial holding
15/02/21 download Created with Sketch. 83.16KB
ATH Change in substantial holding
15/02/21 download Created with Sketch. 1.88MB
ATH Change in substantial holding
12/02/21 download Created with Sketch. 82.47KB
ATH Appendix 2A and Section 708A(5) Cleansing Notice
11/02/21 download Created with Sketch. 376.65KB
ATH Change in substantial holding
11/02/21 download Created with Sketch. 1.06MB
ATH Proposed issue of Securities - ATH
10/02/21 download Created with Sketch. 24.45KB
ATH Michael J Fox grant for Parkinson's research on ATH434
09/02/21PRICE SENSITIVE download Created with Sketch. 192.69KB
ATH Appendix 4C and Quarterly Cash Flow Report
28/01/21PRICE SENSITIVE download Created with Sketch. 338.79KB
ATH Change in substantial holding
14/01/21 download Created with Sketch. 83.8KB
ATH Alterity participates in JP Morgan healthcare conference
11/01/21PRICE SENSITIVE download Created with Sketch. 201KB
ATH Dr David Stamler Appointed CEO
07/01/21PRICE SENSITIVE download Created with Sketch. 258.79KB
ATH Change in substantial holding
29/12/20 download Created with Sketch. 1.06MB
ATH Form F-3
24/12/20PRICE SENSITIVE download Created with Sketch. 300.42KB
ATH New commercial opportunity for PBT2
21/12/20PRICE SENSITIVE download Created with Sketch. 288.04KB
ATH Change in substantial holding
18/12/20 download Created with Sketch. 1.88MB
ATH Form 6-K
17/12/20 download Created with Sketch. 236.7KB
ATH Prospectus Supplement
17/12/20 download Created with Sketch. 663.67KB
ATH Change in substantial holding
10/12/20 download Created with Sketch. 1.06MB
ATH Change in substantial holding
04/12/20 download Created with Sketch. 1.06MB
ATH Form S-8
03/12/20 download Created with Sketch. 175.12KB
ATH Alterity presents at Finance News Network
02/12/20PRICE SENSITIVE download Created with Sketch. 756.28KB
ATH Change in substantial holding
01/12/20 download Created with Sketch. 961.12KB
ATH Change in substantial holding
01/12/20 download Created with Sketch. 1.89MB
ATH Becoming a substantial holder
26/11/20 download Created with Sketch. 83.47KB
ATH Change in substantial holding
26/11/20 download Created with Sketch. 205.8KB
ATH Change in substantial holding
25/11/20 download Created with Sketch. 1.88MB
ATH Prospectus filed pursuant to SEC Rule 424(b)(3)
24/11/20PRICE SENSITIVE download Created with Sketch. 261.13KB
ATH Appendix 3G
24/11/20 download Created with Sketch. 344.97KB
ATH Appendix 2A and Section 708A(5) Cleansing Notice
24/11/20 download Created with Sketch. 377.12KB
ATH Change in substantial holding
24/11/20 download Created with Sketch. 266.43KB
ATH Change in substantial holding
23/11/20 download Created with Sketch. 1.95MB
ATH Change in substantial holding
19/11/20 download Created with Sketch. 1.89MB
ATH ATH Constitution (amended)
18/11/20 download Created with Sketch. 433.08KB
ATH Results of Annual General Meeting
18/11/20 download Created with Sketch. 190.51KB
ATH ATH Annual General Meeting Presentation
18/11/20PRICE SENSITIVE download Created with Sketch. 1.83MB
ATH Chairman's Address 2020 Annual General Meeting
18/11/20PRICE SENSITIVE download Created with Sketch. 235.47KB
ATH Ceasing to be a substantial holder
16/11/20 download Created with Sketch. 479.12KB
ATH Form F-3
16/11/20 download Created with Sketch. 476.25KB
ATH Ceasing to be a substantial holder
16/11/20 download Created with Sketch. 244.1KB
ATH US patent for next generation neurodegenerative diseases
16/11/20PRICE SENSITIVE download Created with Sketch. 180.99KB
ATH Becoming a substantial holder
13/11/20 download Created with Sketch. 525.91KB
ATH Appendix 4C and Quarterly Cash Flow Report
30/10/20PRICE SENSITIVE download Created with Sketch. 353.74KB
ATH MSA patients enrolled in bioMUSE Study
27/10/20PRICE SENSITIVE download Created with Sketch. 184.03KB
ATH Change in substantial holding
27/10/20 download Created with Sketch. 1.89MB
ATH Change in substantial holding
26/10/20 download Created with Sketch. 1.78MB
ATH Alterity completes Placement Tranche 1 raising $10M
23/10/20PRICE SENSITIVE download Created with Sketch. 205.61KB
ATH Appendix 2A and Section 708A(5) Cleansing Notice
23/10/20 download Created with Sketch. 368.87KB
ATH Notice of Annual General Meeting/Proxy Form
20/10/20 download Created with Sketch. 706.22KB
ATH Proposed issue of Securities - ATH
16/10/20 download Created with Sketch. 28.26KB
ATH Proposed issue of Securities - ATH
16/10/20 download Created with Sketch. 25.18KB
ATH Alterity raises $35M in placement to institutional investors
16/10/20PRICE SENSITIVE download Created with Sketch. 234.89KB
ATH Trading Halt
12/10/20PRICE SENSITIVE download Created with Sketch. 164.99KB
ATH Form F-3
06/10/20 download Created with Sketch. 295KB
ATH Form S-8
24/09/20 download Created with Sketch. 126.01KB
ATH Change of Director's Interest Notice x 5
21/09/20 download Created with Sketch. 341.48KB
ATH Appendix 3G Notice of issue of ESOP Options
18/09/20 download Created with Sketch. 351.67KB
ATH Form 20-F
16/09/20PRICE SENSITIVE download Created with Sketch. 2.41MB
ATH ATH filed Form 20-F and XBRL data with SEC
16/09/20 download Created with Sketch. 175.79KB
ATH Appendix 4G and 2020 Corporate Governance Statement
09/09/20 download Created with Sketch. 374.22KB
ATH Annual Report 2020
09/09/20 download Created with Sketch. 2.37MB
ATH Company update on Annual Report 2020
09/09/20PRICE SENSITIVE download Created with Sketch. 177.51KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.5¢
Change
0.002(15.4%)
Mkt cap ! $138.1M
Open High Low Value Volume
1.4¢ 1.5¢ 1.4¢ $70.41K 5.037M

Buyers (Bids)

No. Vol. Price($)
2 95000 1.4¢
 

Sellers (Offers)

Price($) Vol. No.
1.5¢ 21150934 14
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.